Bach2 in CD4 + T cells from SLE patients modulates B-cell differentiation and IgG production.

T and B cells participate in the development of systemic lupus erythematosus (SLE). BTB and CNC homology 2 (Bach2) is an irreplaceable regulator in the T and B lineages that helps to maintain immune homeostasis. However, the function of Bach2 in the pathogenesis of SLE has not been studied in depth. Flow cytometry and qRT-PCR were used to assess Bach2 levels, bisulfite sequencing PCR (BSP) was used to measure the methylation level, and silencing by electroporation and stimulation with a cytokine concentration gradient were used to investigate the effect of Bach2 on T cells. Bach2 expression was elevated in the helper T-cell subsets (Tfh, Th1, Th2, Th17 and Treg cells) of SLE patients and negatively correlated with disease severity and autoantibody levels. CD4 + T cells from SLE patients had decreased methylation levels in the Bach2 promoter region. Silencing Bach2 in CD4 + T cells induced increases in the CD19 + B-cell count, plasmablasts and secretion of IgG by prompting the secretion of cytokines. The activation signals CD3/CD28, IL-6 and IL-21 upregulated Bach2 expression in CD4 + T cells. The regulation of Bach2 by cytokines and T-cell activation signals in CD4 + T cells was shown to act on B cells and play a protective role against SLE. This article is protected by copyright. All rights reserved.